GKHT Medical Valuation
| 301370 Stock | 11.56 0.05 0.43% |
At this time, the firm appears to be overvalued. GKHT Medical Technology retains a regular Real Value of USD10.56 per share. The prevalent price of the firm is USD11.56. Our model calculates the value of GKHT Medical Technology from examining the firm fundamentals such as Return On Asset of 0.0221, return on equity of 0.0677, and Operating Margin of 0.03 % as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 2.224 | Enterprise Value 5.8 B | Enterprise Value Ebitda 22.2512 | Price Sales 0.7371 | Trailing PE 32.2286 |
Overvalued
Today
Please note that GKHT Medical's price fluctuation is not too volatile at this time. Calculation of the real value of GKHT Medical Technology is based on 3 months time horizon. Increasing GKHT Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since GKHT Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GKHT Stock. However, GKHT Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.56 | Real 10.56 | Hype 11.57 | Naive 10.93 |
The real value of GKHT Stock, also known as its intrinsic value, is the underlying worth of GKHT Medical Technology Company, which is reflected in its stock price. It is based on GKHT Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of GKHT Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of GKHT Medical Technology helps investors to forecast how GKHT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GKHT Medical more accurately as focusing exclusively on GKHT Medical's fundamentals will not take into account other important factors: GKHT Medical Total Value Analysis
GKHT Medical Technology is presently forecasted to have takeover price of 5.84 B with market capitalization of 5.31 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the GKHT Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.84 B | 5.31 B |
GKHT Medical Asset Utilization
One of the ways to look at asset utilization of GKHT is to check how much profit was generated for every dollar of assets it reports. GKHT Medical harnesses its resources almost 0.0221 (percent), securing 0.0221 cents for each dollar of resources held by the firm. An expanding asset utilization attests that the company is being more capable with each dollar of resources it retains. Simply put, asset utilization of GKHT Medical shows how capable it operates for each dollar spent on its resources.GKHT Medical Ownership Allocation
GKHT Medical Technology has a total of 470.6 Million outstanding shares. GKHT Medical secures substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates GKHT Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in GKHT Medical and how it compares across the competition.
About GKHT Medical Valuation
The stock valuation mechanism determines GKHT Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of GKHT Medical. We calculate exposure to GKHT Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GKHT Medical's related companies.Complementary Tools for GKHT Stock analysis
When running GKHT Medical's price analysis, check to measure GKHT Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GKHT Medical is operating at the current time. Most of GKHT Medical's value examination focuses on studying past and present price action to predict the probability of GKHT Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GKHT Medical's price. Additionally, you may evaluate how the addition of GKHT Medical to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |